Danaher Corp

Latest Danaher Corp News and Updates

  • uploads///DHR
    Fund Managers

    Glenview Capital opens new position in Danaher

    Glenview Capital Management added a new position in Danaher Corp. (DHR) in the third quarter. The position accounted for 1.99% of the fund’s total portfolio.

    By Samantha Nielson
  • uploads///ecl pm
    Company & Industry Overviews

    Sterne Agee CRT Rated Ecolab as a ‘Buy’

    Ecolab (ECL) reported fiscal 4Q15 net sales of $3,412.0 million—a fall of 7.3% compared to net sales of $3,680.8 million in fiscal 4Q14.

    By Gabriel Kane
  • uploads///recommendations
    Company & Industry Overviews

    What Wall Street Analysts Recommend for Dentsply Sirona

    Dentsply Sirona (XRAY), one of the leading dental technology providers in the United States, recently outlined a turnaround plan to recover from the company’s disappointing performance in recent years.

    By Sarah Collins
  • uploads///kyle sterk  unsplash
    Company & Industry Overviews

    ALGN Stock Surpasses the S&P 500 Index’s Year-to-Date Gain

    On September 28, Align Technology (ALGN) posted an ~74% increase year-to-date. In the same period, the S&P 500 Index has returned ~9%.

    By Sarah Collins
  • uploads///part
    Company & Industry Overviews

    Danaher Corporation’s Excess Returns Fail to Impress

    Earlier in this series, we looked at Danaher’s return on invested capital on a standalone basis. However, we were only looking at half the story.

    By Shannon Black
  • uploads///ecl pm
    Company & Industry Overviews

    Credit Suisse Raised Ecolab Price Target to $109 per Share

    Ecolab (ECL) reported fiscal 4Q15 net sales of $3,412.0 million, a fall of 7.3% compared to net sales of $3,680.8 million in fiscal 4Q14.

    By Gabriel Kane
  • uploads///FNF
    Fund Managers

    Glenview Capital increases stake in Fidelity National Financial

    Glenview Capital Management added to its position in Fidelity National Financial (FNF) in the third quarter. Currently, the position accounts for 1.70% of the fund’s total portfolio.

    By Samantha Nielson
  • uploads///part a
    Earnings Report

    Why Danaher Is Relatively Immune from Growth Concerns in China

    Organically, Danaher (DGR) has grown at a CAGR of roughly 10% in China over the last five years. Approximately 50% of the company’s revenues in China are derived from its Diagnostics segment.

    By Shannon Black
  • uploads///gks pay
    Earnings Report

    Verifone Systems Expands in 3Q15

    Verifone Systems (PAY), with a market cap of $3.38 billion, is a leader in providing payment terminals, global payment as a service, and commerce enablement solutions.

    By Gabriel Kane
  • uploads///ENDP
    Fund Managers

    Glenview Capital raises position in Endo International

    Glenview Capital Management added to its position in Endo International Plc (ENDP) in the third quarter. Currently, the position accounts for 2.02% of the fund’s total portfolio.

    By Samantha Nielson
  • uploads///part
    Company & Industry Overviews

    Dover Fluids: A Brief Overview

    Dover Corporation’s (DOV) Fluids businesses include the Pump Solutions Group (or PSG), which provides pumping solutions to several end markets.

    By Shannon Black
  • uploads///tooth _
    Earnings Report

    Analysts Cut Their Targets for XRAY ahead of Its 1Q18 Results

    Dentsply Sirona, one of the leading dental technology providers in the United States, will announce its 1Q18 earnings results on May 7.

    By Sarah Collins
  • Healthcare

    Must-know: Why did firms report a sharp spike in wages in May?

    Manufacturing growth appears to be steady in the Fifth District. Although new orders declined sharply month-on-month, firms remained upbeat for business prospects.

    By Phalguni Soni
  • uploads///GE
    Industrials

    GE Stock Upgraded by UBS with a ‘Buy,’ $14 Price Target

    Markus Mittermaier, a new analyst at UBS, gave GE stock a “buy” rating yesterday. Previously, UBS offered a “neutral” rating on the stock.

    By Mike Sonnenberg
  • uploads///GE
    Industrials

    Will the New GE CFO Achieve Larry Culp’s Goals?

    Today, GE announced that Carolina Dybeck Happe will take charge as chief financial officer or CFO at GE, replacing from Jamie Miller early next year.

    By Mike Sonnenberg
  • uploads///GE stock
    Earnings Report

    Could Earnings and Culp Continue to Boost GE Stock?

    The third quarter was tough for multinational conglomerate General Electric (GE). Between July 1 and September 30, GE stock lost 15% of its value.

    By Mike Sonnenberg
  • Industrials

    Why do key purchasing managers’ index readings move markets?

    In this series, we’ll focus on the manufacturing PMI issued by three major institutions, measuring manufacturing activity in the U.S.

    By Phalguni Soni
  • uploads///Turnaround
    Financials

    GE Stock Gains, Citigroup Sees Meaningful Turnaround

    On Wednesday, General Electric (GE) stock rose 5.6% after a top Wall Street analyst made some positive remarks about its turnaround efforts.

    By Anirudha Bhagat
  • uploads///Align technolgies
    Company & Industry Overviews

    Align Technology Stock Recovers after Tanking Last Week

    Align Technology stock (ALGN) took a massive hit after Q2 earnings. So what was behind the massive decline, and what’s helping the stock recover?

    By Sushree Mohanty
  • uploads///GE Turbine
    Earnings Report

    Could GE’s Q2 Results Surprise Investors Again?

    General Electric (GE) is slated to report its Q2 results on Wednesday. Let’s look at what analysts expect from the company in the second quarter.

    By Anirudha Bhagat
  • uploads///Chart  Total Debt
    Company & Industry Overviews

    BioPharma Sale to Strengthen General Electric’s Balance Sheet

    In late February, General Electric (GE) made a breakthrough toward reducing its debt obligation and strengthening its balance sheet.

    By Anirudha Bhagat
  • uploads///turbine _
    Energy & Utilities

    GE Wraps Up Q1 with a 37% Gain in Its Stock Price

    Shares of GE have been surging since the beginning of the year and have probably seen the highest gain ever in a first quarter.

    By Anirudha Bhagat
  • uploads///turbine _
    Company & Industry Overviews

    GE Fell ~8% after J.P. Morgan Warned of More Downside Risk

    GE stock extended its declines for the second consecutive day after a JPMorgan Chase analyst warned of more downside risk to the stock.

    By Anirudha Bhagat
  • uploads///turbine _
    Company & Industry Overviews

    GE Soared after Larry Culp Stresses Debt Cut and Dividend Boost

    General Electric (GE) was trading 1.4% higher in pre-market trading today after CEO Larry Culp reassured investors the company would return to a “position of strength.”

    By Anirudha Bhagat
  • uploads///turbine _
    Healthcare

    GE Shares Rose 2.5%, Analysts Turned Bullish on the Stock

    On February 26, General Electric (GE) shares rose after several analysts provided positive comments about its recent deal.

    By Anirudha Bhagat
  • uploads///growth _
    Company & Industry Overviews

    Buffett Missing in Action as GE’s Turnaround Plan Gets Upvote

    General Electric (GE) is up 9.1% today as of 11:50 AM ET. GE has announced that that it has entered a definitive agreement to sell its Biopharma business to Danaher (DHR).

    By Mohit Oberoi, CFA
  • uploads///truck _
    Company & Industry Overviews

    Year-Long GE Transportation-Wabtec Merger Completed

    General Electric (GE) closed the year-long pending merger of its Transportation business unit with Wabtec today.

    By Anirudha Bhagat
  • uploads///turbine _
    Company & Industry Overviews

    GE Stock Rises on Announcement of BioPharma Unit Sale to Danaher

    General Electric (GE) revealed today that it has entered a definitive agreement to sell its BioPharma business to Danaher.

    By Anirudha Bhagat
  • uploads///ILMN
    Company & Industry Overviews

    Analysts Remain Bullish on Illumina Stock

    In November, of the 19 analysts covering Illumina (ILMN), 14 have given it “buy” or higher ratings, and five have given it “hold” ratings.

    By Kenneth Smith
  • uploads///ILMN
    Company & Industry Overviews

    Understanding Illumina’s Gross Margin Trend

    Illumina’s cost of product revenue increased from $173.0 million in the third quarter of 2017 to $184.0 million in the third quarter of 2018.

    By Kenneth Smith
  • uploads///ILMN
    Company & Industry Overviews

    Understanding Illumina’s Geographical Performance

    For 2018 and 2019, Illumina is expected to generate revenues of $3.33 billion and $3.80 billion, respectively.

    By Kenneth Smith
  • uploads///WAT ana reco
    Company & Industry Overviews

    What Waters Corporation’s Valuation Trend Indicates

    In September, of the 15 analysts covering Waters Corporation (WAT) stock, ten have given it “holds.”

    By Kenneth Smith
  • uploads///rawpixel  unsplash
    Company & Industry Overviews

    Analyzing Perrigo’s Spin-Off of Its Rx Business

    In this series, we’ll analyze major spin-offs in the healthcare sector by Perrigo (PRGO), Eli Lilly (LLY), Danaher (DHR), and Henry Schein.

    By Kenneth Smith
  • uploads///NEW SEGMENT STRUCTUR
    Company & Industry Overviews

    Understanding Dentsply Sirona’s New Organizational Structure

    In 4Q17, Dentsply Sirona (XRAY) started reporting its operations under two segments, after a shift to three segments in fiscal 3Q17.

    By Sarah Collins
  • uploads///Part  Recommendations
    Materials

    Why Analysts Are Positive on W.R. Grace

    In the past six months, the number of analysts covering W.R. Grace (GRA) has fallen from 14 to the present 11.

    By Peter Neil
  • uploads///peter kasprzyk  unsplash
    Company & Industry Overviews

    Why Is Wall Street Still Upbeat on Dentsply Sirona’s Growth Potential in 2018?

    Dentsply Sirona is a leading dental technology, equipment, and consumables provider in the US. But it has been going through some tough times.

    By Sarah Collins
  • uploads///Part  short interestQ DVD
    Company & Industry Overviews

    What Short Interest in Stanley Black & Decker Suggests

    Data from February 28, 2018, shows that Stanley Black & Decker’s (SWK) short interest has fallen since the beginning of 2018.

    By Peter Neil
  • uploads///greyson joralemon  unsplash
    Company & Industry Overviews

    Could Stanley Black & Decker Stock Bounce Back?

    Stanley Black & Decker (SWK) stock has remained low since the beginning of 2018.

    By Peter Neil
  • uploads///leading portfolio
    Company & Industry Overviews

    Developments in Dentsply Sirona’s Digital Dentistry Portfolio

    On September 20, 2017, Dentsply Sirona (XRAY) announced an enhancement to its Galileos Implant software.

    By Sarah Collins
  • uploads///leading portfolio
    Company & Industry Overviews

    Dentsply Sirona’s Newly Launched Cerec Zirconia Meso Block

    In August 2017, Dentsply Sirona (XRAY) launched its Cerec Zirconia Meso Block for creating customized screw-retained crowns.

    By Sarah Collins
  • uploads///recommendations
    Company & Industry Overviews

    What Analysts Are Recommending for Dentsply Sirona

    According to the recommendations of 15 brokerage firms, 60.0% (or nine) of them have rated Dentsply Sirona (XRAY) a “buy,” and 33.0% (or five) have rated it a “hold.”

    By Sarah Collins
  • uploads///recommendations
    Company & Industry Overviews

    What Do Analysts Recommend for Dentsply Sirona?

    Based on the recommendations of 16 brokerage companies, around 63% (or ten) of the analysts provided a “buy” recommendation for Dentsply Sirona.

    By Sarah Collins
  • uploads///PROJECTIONS
    Company & Industry Overviews

    Discussing Dentsply Sirona’s Updated 2017 Guidance

    Dentsply Sirona made a downward revision to its fiscal 2017 guidance during the company’s 2Q17 earnings results announcement on August 9, 2017.

    By Sarah Collins
  • uploads///REVENUES BY SEGMENT
    Company & Industry Overviews

    Dentsply Sirona’s Technologies Segment Sales Declined in 2Q17

    In 2Q17, Dentsply Sirona’s (XRAY) Technologies business contributed ~44% to the company’s total revenues and registered sales of ~$439 million.

    By Sarah Collins
  • uploads///Graph
    Company & Industry Overviews

    Align Technology Focuses on International Market Strategy

    International market strategy In 2Q17, Align Technology (ALGN) reported 85,400 Invisalign case shipments in international markets, which is YoY (year-over-year) growth of ~37.4% and sequential growth of ~13.6%. This growth was mainly attributed to new customers in the EMEA (Europe, the Middle East, and Africa) and Asia-Pacific markets. If Align Technology continues to demonstrate solid […]

    By Margaret Patrick
  • uploads///Graph
    Company & Industry Overviews

    Inside Align Technology’s Market Expansion Strategy

    In 1Q17, Align Technology (ALGN) also witnessed a robust rise of around 45.2% in volumes of Invisalign sold in Asia-Pacific markets on a YoY basis.

    By Margaret Patrick
  • uploads///Graph
    Company & Industry Overviews

    Understanding Align Technology’s Growing Position in International Markets

    In 1Q17, Align Technology (ALGN) witnessed an 11.4% sequential rise in the volume of Invisalign cases used by doctors in international markets.

    By Margaret Patrick
  • uploads///Graph
    Company & Industry Overviews

    These Are Align Technologies Key Demand Drivers in North America

    In 1Q17, Align Technology (ALGN) has started selling its new product Invisalign Go in North America, which involves a few DSOs (dental service organizations).

    By Margaret Patrick
  • uploads///Graph
    Company & Industry Overviews

    Behind Align Technology’s North American Expectations for 2017

    In 1Q17, Align Technology’s (ALGN) Invisalign sales volumes in North American markets rose YoY by 20.3% and QoQ by 8.3%.

    By Margaret Patrick
  • uploads///Graph
    Company & Industry Overviews

    Why Align Technology’s Orthodontics Is a Solid Growth Opportunity in 2017

    Align Technology (ALGN) is a medical device provider focused on malocclusion or teeth misalignment condition.

    By Margaret Patrick
  • uploads///Graph
    Company & Industry Overviews

    Inside Align Technology’s Robust Revenue Growth Projection for 2017

    For fiscal 2017, Align Technology (ALGN) expects its 2017 revenues to grow operationally in the range of 15%–25% YoY.

    By Margaret Patrick
  • uploads///Graph
    Company & Industry Overviews

    Align Technology versus Peers in June 2017: Analyst Recommendations

    For 1Q17, Align Technology (ALGN) reported revenues close to $310.3 million, which represents YoY (year-over-year) growth of around 30.0%.

    By Margaret Patrick
  • uploads///Graph
    Company & Industry Overviews

    What Bio-Rad Laboratories Expects from Life Science

    In 1Q17, Bio-Rad Laboratories’ (BIO) Life Science segment reported revenues of ~$174.3 million, which represents a YoY rise of ~5.1%.

    By Margaret Patrick
  • uploads///Graph
    Company & Industry Overviews

    Inside Bio-Rad Laboratories’ Robust Revenue Growth Projection for 2017

    On March 13, 2017, Bio-Rad Laboratories (BIO) provided a long-term, currency-neutral revenue growth target of around 3%–5%.

    By Margaret Patrick
  • uploads///Graph
    Company & Industry Overviews

    Bio-Rad Laboratories on the Street: Analysts’ Recommendations in May

    In 1Q17, Bio-Rad Laboratories (BIO) reported revenues of ~$500.1 million, which represented a YoY (year-over-year) rise of around 6.1%.

    By Margaret Patrick
  • uploads///revenues by segment
    Earnings Report

    Dentsply Sirona’s New Growth Strategy to Accelerate Digital Dentistry Penetration

    Dentsply Sirona is the largest dental equipment and solutions manufacturer in the United States. Digital dentistry is a megatrend in the market.

    By Sarah Collins
  • uploads///segment revenues
    Earnings Report

    How Did Danaher’s Operating Segments Fare in 4Q16?

    Currently, Danaher (DHR) reports its revenue under four operating segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.

    By Sheldon Krieger
  • uploads///stock
    Earnings Report

    Why Danaher Stock Rose after Its 4Q16 Results

    Danaher Corporation (DHR) announced its 4Q16 and 2016 earnings results before the market opened on January 31, 2017. Let’s take a look.

    By Sheldon Krieger
  • uploads///stock price
    Earnings Report

    What Factors Could Drive Danaher Stock in 2017?

    Danaher Corporation (DHR) will announce its 4Q16 earning results before the market opens on January 31, 2017. What should we expect?

    By Sheldon Krieger
  • uploads///ecl pm
    Company & Industry Overviews

    Ecolab Declares a Dividend of $0.37 per Share

    Price movement Ecolab (ECL) has a market cap of $35.4 billion. It rose 0.67% to close at $119.61 per share on December 8, 2016. The stock’s weekly, monthly, and year-to-date (or YTD) price movements were 0.95%, 5.3%, and 5.5%, respectively, on the same day. ECL is trading 3.0% above its 20-day moving average, 2.7% above […]

    By Gabriel Kane
  • uploads///danaher phenomenex
    Earnings Report

    With Phenomenex, Danaher Has an Attractive Consumables Asset

    On October 12, Danaher announced its an agreement to acquire Phenomenex, a privately held manufacturer of separation and purification consumables.

    By Shannon Black
  • uploads///T Rowe Price Blue Chip Growth Fund
    Company & Industry Overviews

    Why the T. Rowe Price Blue Chip Growth Fund Has Had a Rough 2016

    TRBCX has had quite a poor run in 2016 so far. The fund places in the bottom three in the YTD period among the 12 funds in this review.

    By David Ashworth
  • uploads///danaher acquires cepheid
    Healthcare

    What Made Cepheid Attractive to Danaher?

    On September 6, 2016, Danaher (DHR) announced that it has entered into a definitive agreement to acquire Cepheid (CPHD) for $4 billion.

    By Shannon Black
  • uploads///danaher diagnostics competitors
    Company & Industry Overviews

    How Danaher Diagnostics Fares against Its Competition

    Danaher’s Diagnostics unit had operating margins of 15.4% in 2015 and 17.2% in 1H16.

    By Shannon Black
  • uploads///danaher pall recurring
    Company & Industry Overviews

    The Key Product Lines That Make Up Danaher’s Diagnostics Business

    Danaher’s (DHR) Diagnostics unit, established through the acquisition of Radiometer in 2004, earned $4.9 billion in sales in 2015.

    By Shannon Black
  • uploads///danaher pall overview
    Company & Industry Overviews

    Pall Acquisition Gave Birth to Danaher’s Filtration Business

    Danaher’s filtration business came into existence through the acquisition of Pall in 2015.

    By Shannon Black
  • uploads///Danaher Life Sciences unit
    Company & Industry Overviews

    Understanding the Skeleton of Danaher’s Life Sciences Business

    Customers in the Danaher life sciences business generally look at how the technology offered by a company can fit into their workflows.

    By Shannon Black
  • uploads///part
    Company & Industry Overviews

    How Are Danaher’s Returns Compared to Its Industry Peers’?

    Danaher’s ROIC fell steadily from 15.5% in 2006 to 8.5% in 2015, indicating that it has probably had fewer high return reinvestment opportunities since then.

    By Shannon Black
  • uploads///part
    Company & Industry Overviews

    Is Danaher Losing Its Competitive Advantage?

    We analyzed Danaher’s (DHR) ROIC in the 20-year period between 1995 and 2015 and classified the period of study into 16 buckets of five years each.

    By Shannon Black
  • uploads///part
    Company & Industry Overviews

    Danaher’s Journey from Corporate Raider to Corporate Statesman

    Danaher (DHR) was the brainchild of brothers Steven and Mitchell Rales. It was incorporated as a holding company in 1984.

    By Shannon Black
  • uploads///part
    Earnings Report

    Parker-Hannifin’s 2017 Guidance Suggests Slowdown in Industrials

    Parker-Hannifin has guided its fiscal 2017 adjusted EPS at $6.40–$7.10. The midpoint of this range is roughly 4.5% higher than $6.46 in fiscal 2016.

    By Shannon Black
  • uploads///Portfolio Breakdown of the MFEGX
    Financials

    Noteworthy Portfolio Changes in the MFS Growth Fund

    The MFS Growth Fund Class A’s assets were invested across 87 holdings as of June 2016, and it was managing assets worth $12 billion as of the end of June.

    By David Ashworth
  • uploads///ecl pm
    Materials

    Ecolab Invests in Aquatech International to Improve Processes

    Ecolab fell by 0.26% to close at $120.95 per share on July 15, 2016. Its weekly, monthly, and YTD price movements were 1.5%, 2.3%, and 6.4%, respectively.

    By Gabriel Kane
  • uploads///part
    Earnings Report

    How Wall Street Views Dover Corporation’s 2Q16 Earnings

    The diversified industrials company Dover Corporation (DOV) is expected to declare its 2Q16 earnings on July 19, 2016. In 1Q16, Dover’s management downgraded its sales guidance, citing weaker fundamentals in the oil and gas markets

    By Shannon Black
  • uploads///ecl pm
    Materials

    Ecolab Acquires Anios and Sees Its Target Price Cut

    Ecolab (ECL) has a market cap of $34.3 billion. Its stock rose by 1.3% to close at $116.79 per share on June 29, 2016.

    By Gabriel Kane
  • uploads///part
    Company & Industry Overviews

    How 3M Company Differs from Other Industrial Conglomerates

    While 3M’s peer group includes industrial conglomerates such as Honeywell and General Electric, these companies hardly share any similarities with 3M.

    By Shannon Black
  • uploads///Total IG Bond Issuance in Week Ending Jun
    Company & Industry Overviews

    Emera US Finance Issued the Most High Grade Bonds Last Week

    Yankee bond issuers dominated the primary high grade bond market in the week ended June 10, making up 30.3%, or $10.2 billion, of all issues.

    By Lynn Noah
  • uploads///part
    Company & Industry Overviews

    Understanding Dover Corporation’s Corporate Profile and History

    Dover Corporation (DOV) is a machinery manufacturer that operates in four diverse segments: Energy, Engineered Systems, Fluids, and Refrigeration & Food Equipment.

    By Shannon Black
  • uploads///ecl pm
    Company & Industry Overviews

    Why Goldman Sachs Downgraded Ecolab to ‘Sell’

    Ecolab has a market cap of $30.5 billion. It fell and closed at $103.04 per share as of March 14. In fiscal 2015, it reported net sales of $13,545.1 million.

    By Gabriel Kane
  • uploads///ecl pm
    Company & Industry Overviews

    Why Barclays Reduced Ecolab’s Price Target

    Ecolab (ECL) has a market cap of $30.2 billion. ECL rose by 2.0% to close at $102.13 per share as of February 24, 2016.

    By Gabriel Kane
  • uploads///ecl pe
    Company & Industry Overviews

    How Does Ecolab Compare to Its Peers?

    The PowerShares Water Resource Portfolio (PHO) invests 7.5% of its holdings in Ecolab.

    By Gabriel Kane
  • uploads///revenue growth
    Company & Industry Overviews

    Becton, Dickinson and Company’s Acquisitions and Collaborations

    Becton, Dickinson and Company’s (BDX), or BD’s, growth strategy includes acquisitions and collaborations.

    By Sarah Collins
  • uploads///cmn pm
    Earnings Report

    Cantel Medical’s Revenue and Income Rise in Fiscal 1Q16

    Cantel Medical (CMN) has a market cap of $2.8 billion. Its YTD (year-to-date) price has been rising quarter-over-quarter in calendar 2015.

    By Gabriel Kane
  • uploads///siro pm
    Earnings Report

    Analyzing Sirona Dental Systems’ Rise in Revenue in Fiscal 4Q15

    After the release of Sirona Dental Systems’ (SIRO) 4Q15 earnings report, SIRO rose by 0.23% to close at $109.22 per share on November 20, 2015.

    By Gabriel Kane
  • uploads///Fed
    Macroeconomic Analysis

    Why the Federal Manufacturing Index Fell in October

    With new orders and shipments indexes turning negative, the Philadelphia Fed Manufacturing Index came in at -4.5 points in October 2015.

    By Lara Sheldon
  • uploads///Article
    Company & Industry Overviews

    How Does Abbott Compare With Its Peers in the Industry?

    The PE multiple is one of the simplest multiples used for valuations. The forward PE ratio for Abbott is ~22x for 2015. It’s ~23.7x for the industry.

    By Mike Benson
  • uploads///Article
    Company & Industry Overviews

    Understanding Leverage for Abbott Laboratories

    Abbott Laboratories (ABT) uses both equity and debt for its working capital requirements as well as investments in the business.

    By Mike Benson
  • uploads///UTX bldg industrial business
    Company & Industry Overviews

    What Is UTC Building & Industrial Systems?

    UTC offers some products and services through UTC Building & Industrial Systems, a combination of two segments, Otis and UTC Climate, Controls & Security.

    By Ally Schmidt
  • uploads///BA Narro body aircrafts
    Company & Industry Overviews

    The Boeing Company’s Narrow-Body Aircraft

    The Boeing 737 is the best-selling commercial airliner in history. Reliable and economical, the 737 dominates the short- and medium-haul markets.

    By Ally Schmidt
  • uploads///BA pension plan
    Company & Industry Overviews

    What to Expect from Boeing’s New Pension Plan

    Boeing offered some former nonunion employees the option of taking a lump-sum payment or an annuity to replace their traditional pension benefits.

    By Ally Schmidt
  • uploads///PNR
    Fund Managers

    Glenview Capital ups position in Pentair

    Glenview Capital Management added to its position in Pentair Plc (PNR) in the third quarter. Currently, the position accounts for 2.41% of the fund’s total portfolio.

    By Samantha Nielson
  • © Copyright 2022 Market Realist. Market Realist is a registered trademark. All Rights Reserved. People may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.